prikaz prve stranice dokumenta Genomics in multiple sclerosis
  Preuzmi
PDF 191.32 KB
Znanstveni rad - Pregledni rad
Genomics in multiple sclerosis
Clinical Neurology and Neurosurgery, 112 (2010), 7; 621-624. https://doi.org/10.1016/j.clineuro.2010.03.028
Habek, Mario; Borovečki, Fran; Brinar, Vesna V.

Citirajte ovaj rad

Habek, M., Borovečki, F. i Brinar, V. V. (2010). Genomics in multiple sclerosis. Clinical Neurology and Neurosurgery, 112. (7), 621-624. doi: 10.1016/j.clineuro.2010.03.028

Habek, Mario, et al. "Genomics in multiple sclerosis." Clinical Neurology and Neurosurgery, vol. 112, br. 7, 2010, str. 621-624. https://doi.org/10.1016/j.clineuro.2010.03.028

Habek, Mario, Fran Borovečki i Vesna V. Brinar. "Genomics in multiple sclerosis." Clinical Neurology and Neurosurgery 112, br. 7 (2010): 621-624. https://doi.org/10.1016/j.clineuro.2010.03.028

Habek, M., Borovečki, F. i Brinar, V. V. (2010) 'Genomics in multiple sclerosis', Clinical Neurology and Neurosurgery, 112(7), str. 621-624. doi: 10.1016/j.clineuro.2010.03.028

Habek M, Borovečki F, Brinar VV. Genomics in multiple sclerosis. Clinical Neurology and Neurosurgery [Internet]. 09.2010. [pristupljeno 11.04.2024.];112(7):621-624. doi: 10.1016/j.clineuro.2010.03.028

M. Habek, F. Borovečki i V. V. Brinar, "Genomics in multiple sclerosis", Clinical Neurology and Neurosurgery, vol. 112, br. 7, str. 621-624, Rujan 2010. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:975777. [Citirano: 11.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:975777
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Genomics in multiple sclerosis
AutorMario Habek
AutorFran Borovečki
AutorVesna V. Brinar
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Multiple sclerosis (MS) is chronic, inflammatory disease of the central nervous system that mainly affects young adults and is characterized with dissemination of demyelinating lesions in time and space. It is well known that MS is very heterogeneous disease, so biomarkers that would reliably determine disease course, outcome or treatment response in early stages of the disease (preferentially clinically isolated syndrome) are desperately needed. Genome-wide expression analysis represents the profile of all genes in a certain tissue or cell population in a certain time point. Therefore, as the sequence of the human genome is entirely known, it is possible to analyze any given human gene in any given context. This review will discuss results and possible applications of genome-wide expression studies in brain tissue and blood samples of MS patients.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaClinical Neurology and Neurosurgery
Brojčani podacivol. 112, br. 7, str. 621-624
p-ISSN0303-8467
DOIhttps://doi.org/10.1016/j.clineuro.2010.03.028
URN:NBNurn:nbn:hr:105:975777
Datum objave publikacije2010-09
URL dokumentahttps://doi.org/10.1016/j.clineuro.2010.03.028
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 11:45:02